• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Medigen Biotechnology Corporation (3176) - Financial and Strategic SWOT Analysis Review - Product Image

Medigen Biotechnology Corporation (3176) - Financial and Strategic SWOT Analysis Review

  • ID: 2051328
  • March 2014
  • 32 pages
  • GlobalData

FEATURED COMPANIES

  • DR. Chip Biotech Inc.
  • PhytoHealth Corporation
  • Taiwan Liposome Company
  • Vita Genomics, Inc.
  • MORE

Medigen Biotechnology Corporation (3176) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees READ MORE >

FEATURED COMPANIES

  • DR. Chip Biotech Inc.
  • PhytoHealth Corporation
  • Taiwan Liposome Company
  • Vita Genomics, Inc.
  • MORE

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Medigen Biotechnology Corporation - Key Facts
Medigen Biotechnology Corporation - Key Employees
Medigen Biotechnology Corporation - Key Employee Biographies
Medigen Biotechnology Corporation - Major Products and Services
Medigen Biotechnology Corporation - Pharmaceutical Pipeline Products Data
Medigen Biotechnology Corporation, Pipeline Products by Therapy Area
Medigen Biotechnology Corporation, Pipeline Products by Development Phase
Medigen Biotechnology Corporation - History
Medigen Biotechnology Corporation - Company Statement
Medigen Biotechnology Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Medigen Biotechnology Corporation - Business Description
Medigen Biotechnology Corporation - SWOT Analysis
SWOT Analysis - Overview
Medigen Biotechnology Corporation - Strengths
Strength - Focused Drug Development
Strength - Core Technology Platform
Strength - Improving Liquidity Reserves
Medigen Biotechnology Corporation - Weaknesses
Weakness - History of Operating Losses
Medigen Biotechnology Corporation - Opportunities
Opportunity - Lead Product Candidate- PI-88
Opportunity - Market Potential: Chinese Pharmaceutical Market
Opportunity - Market Potential: Oncology
Medigen Biotechnology Corporation - Threats
Threat - Compliance with Government Regulations
Threat - Rapid Technological Changes
Threat - Competitive Atmosphere
Medigen Biotechnology Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Medigen Biotechnology Corporation, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Medigen Biotechnology Corporation, Key Facts
Medigen Biotechnology Corporation, Key Employees
Medigen Biotechnology Corporation, Key Employee Biographies
Medigen Biotechnology Corporation, Major Products and Services
Medigen Biotechnology Corporation, Number of Pipeline Products by Therapy Area
Medigen Biotechnology Corporation, Number of Pipeline Products by Development Stage
Medigen Biotechnology Corporation, Pipeline Products By Therapy Area and Development Phase
Medigen Biotechnology Corporation, History
Medigen Biotechnology Corporation, Subsidiaries
Medigen Biotechnology Corporation, Key Competitors
Medigen Biotechnology Corporation, Ratios based on current share price
Medigen Biotechnology Corporation, Annual Ratios
Medigen Biotechnology Corporation, Interim Ratios
Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Medigen Biotechnology Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Medigen Biotechnology Corporation, Pipeline Products by Therapy Area
Medigen Biotechnology Corporation, Pipeline Products by Development Phase
Medigen Biotechnology Corporation, Performance Chart (2008 - 2012)
Medigen Biotechnology Corporation, Ratio Charts
Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Medigen Biotechnology Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014

Vita Genomics, Inc.
PhytoHealth Corporation
DR. Chip Biotech Inc.
Development Center for Biotechnology
Taiwan Liposome Company

Note: Product cover images may vary from those shown

RELATED PRODUCTS